Trials / Unknown
UnknownNCT05719181
Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.
Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study of 6\12\2021 to20\4\2023
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- University of Baghdad · Academic / Other
- Sex
- All
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Effect of Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.
Detailed description
The Primary outcome will be measuring the effect of rhBMP- 2/ACS in improving the secondary stability of dental implant by using RFA in comparison to control group. Secondary outcome association of the effect of other factors (ridge dimension, bone density) on dental implant stability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | rhBMP-2 | Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge . |
Timeline
- Start date
- 2021-12-06
- Primary completion
- 2023-03-18
- Completion
- 2023-04-20
- First posted
- 2023-02-08
- Last updated
- 2023-02-08
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT05719181. Inclusion in this directory is not an endorsement.